The place of sulfonylureas in the therapy for type 2 diabetes mellitus
- Author
- DEL PRATO, Stefano1 ; PULIZZI, Nicolo1
[1] Department of Endocrinology and Metabolism, Section of Diabetes and Metabolic Diseases, University of Pisa, Italy - Conference title
- Sulfonylureas in the therapy of type 2 diabetes: where do we stand today?: Proceedings of a symposium held on the occasion of the 41st Annual Meeting of the European Association for the Study of Diabetes, September 11, 2005
- Conference name
- Satellite Symposium Sulfonylureas in the therapy of type 2 diabetes: Where do we stand today? (Athens 2005-09-11)
- Author (monograph)
- DEL PRATO, Stefano (Editor)1
[1] Department of Endocrinology and Metabolism, Section of Diabete s, University of Pisa, Italy - Source
Metabolism, clinical and experimental. 2006, Vol 55, Num 5 ; S20-S27 ; SUP1 ; ref : 60 ref
- ISSN
- 0026-0495
- Scientific domain
- Endocrinology; Nutrition, obesity, metabolic disorders
- Publisher
- Elsevier, New York, NY
- Publication country
- United States
- Document type
- Conference Paper
- Language
- English
- Keyword (fr)
- Diabète type 2 Sulfonylurées Traitement Endocrinopathie Métabolisme pathologie
- Keyword (en)
- Type 2 diabetes Sulfonylureas Treatment Endocrinopathy Metabolic diseases
- Keyword (es)
- Diabetes de tipo 2 Sulfonilureas Tratamiento Endocrinopatía Metabolismo patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B21 Endocrinopathies / 002B21E Endocrine pancreas. Apud cells (diseases) / 002B21E01 Diabetes. Impaired glucose tolerance / 002B21E01A Etiopathogenesis. Screening. Investigations. Target tissue resistance
- Discipline
- Endocrinopathies Metabolic diseases
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 17828307
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:70:\"The place of sulfonylureas in the therapy for type 2 diabetes mellitus\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Metabolism, clinical and experimental\";s:9:\"\u0000*\u0000stitle\";s:16:\"Metab. clin. exp\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"55\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:7:\"S20-S27\";s:7:\"\u0000*\u0000issn\";s:9:\"0026-0495\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"DEL PRATO\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Stefano\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:15:\"PULIZZI, Nicolo\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:4:\"SUP1\";s:9:\"\u0000*\u0000btitle\";s:223:\"Sulfonylureas in the therapy of type 2 diabetes: where do we stand today?: Proceedings of a symposium held on the occasion of the 41st Annual Meeting of the European Association for the Study of Diabetes, September 11, 2005\";s:8:\"\u0000*\u0000title\";s:70:\"The place of sulfonylureas in the therapy for type 2 diabetes mellitus\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:70:\"The place of sulfonylureas in the therapy for type 2 diabetes mellitus\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Metabolism, clinical and experimental\";s:9:\"\u0000*\u0000stitle\";s:16:\"Metab. clin. exp\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"55\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:7:\"S20-S27\";s:7:\"\u0000*\u0000issn\";s:9:\"0026-0495\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"DEL PRATO\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Stefano\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:15:\"PULIZZI, Nicolo\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:4:\"SUP1\";s:9:\"\u0000*\u0000btitle\";s:223:\"Sulfonylureas in the therapy of type 2 diabetes: where do we stand today?: Proceedings of a symposium held on the occasion of the 41st Annual Meeting of the European Association for the Study of Diabetes, September 11, 2005\";s:8:\"\u0000*\u0000title\";s:70:\"The place of sulfonylureas in the therapy for type 2 diabetes mellitus\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:70:\"The place of sulfonylureas in the therapy for type 2 diabetes mellitus\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Metabolism, clinical and experimental\";s:9:\"\u0000*\u0000stitle\";s:16:\"Metab. clin. exp\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"55\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:7:\"S20-S27\";s:7:\"\u0000*\u0000issn\";s:9:\"0026-0495\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"DEL PRATO\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Stefano\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:15:\"PULIZZI, Nicolo\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:4:\"SUP1\";s:9:\"\u0000*\u0000btitle\";s:223:\"Sulfonylureas in the therapy of type 2 diabetes: where do we stand today?: Proceedings of a symposium held on the occasion of the 41st Annual Meeting of the European Association for the Study of Diabetes, September 11, 2005\";s:8:\"\u0000*\u0000title\";s:70:\"The place of sulfonylureas in the therapy for type 2 diabetes mellitus\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:70:\"The place of sulfonylureas in the therapy for type 2 diabetes mellitus\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Metabolism, clinical and experimental\";s:9:\"\u0000*\u0000stitle\";s:16:\"Metab. clin. exp\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"55\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:7:\"S20-S27\";s:7:\"\u0000*\u0000issn\";s:9:\"0026-0495\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"DEL PRATO\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Stefano\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:15:\"PULIZZI, Nicolo\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:4:\"SUP1\";s:9:\"\u0000*\u0000btitle\";s:223:\"Sulfonylureas in the therapy of type 2 diabetes: where do we stand today?: Proceedings of a symposium held on the occasion of the 41st Annual Meeting of the European Association for the Study of Diabetes, September 11, 2005\";s:8:\"\u0000*\u0000title\";s:70:\"The place of sulfonylureas in the therapy for type 2 diabetes mellitus\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
